- Capital Cube•10 days ago
Categories: Yahoo Finance Get free summary analysis NexgenRx, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of NexgenRx, Inc. – PharMerica Corporation, Express Scripts Holding Company and Ligand Pharmaceuticals Incorporated (PMC-US, ESRX-US and LGND-US) that have also reported for this period. Highlights Summary numbers: Revenues of ... Read more (Read more...)
- Marketwired•29 days ago
NEXGENRX INC. announces revenue of $1,565,891 an increase of $394,280 over the same period last year. Gross profit was $1,278,834 up $349,162 producing net quarterly income of $89,363. Revenue for the ...
- Marketwired•3 months ago
NEXGENRX INC. announces the election of two new directors at its recently held annual and special meeting of its shareholders. Connie Graham of London, Ontario and Catherine Novick of Toronto, Ontario, ...
NexgenRx, Inc. (NXG.V)
TSXV - TSXV Delayed Price. Currency in CAD
|Day's Range||0.18 - 0.19|
|52wk Range||0.14 - 0.20|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-63.33|
|Avg Vol (3m)||66,215|
|Dividend & Yield||N/A (N/A)|